GlyTech
Latest round
- Series C
Last raised
- Jun 2020
Total raised
- $17M
Investors
- 8
About GlyTech
Founded in 2009 and based in Kyoyo, Japan, GlyTech, Inc. manufactures human type N-glycans and develops glycosylation technologies, glycopeptide synthesis, and glycoprotein synthesis. It also manages a library of human-type asparagine(Asp)-linked glycans which can be used in research and production.
Who invested in GlyTech
8 investors across 3 rounds
See all investors in GlyTech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about GlyTech
Who invested in GlyTech?
GlyTech has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has GlyTech raised?
GlyTech has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did GlyTech last raise money?
GlyTech's most recent round on record is a Series C, in Jun 2020.
What does GlyTech do?
Founded in 2009 and based in Kyoyo, Japan, GlyTech, Inc.
Where is GlyTech headquartered?
GlyTech is headquartered in Kyoto, Japan.
Which VCs invest in companies like GlyTech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biopolymers companies at GlyTech's stage. Their profiles are linked below.
VCs backing biopolymers startups at Series C
Raising like GlyTech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.